Health Trials

Primary Central Nervous System Tumors Harboring NTRK Fusion

1

Review clinical trials related to Primary Central Nervous System Tumors Harboring NTRK Fusion. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of ICP-723 in Patients With Advanced Solid Tumors or Primary Central Nervous System Tumors

A Multi-center, Non-Randomized, Open-Label Phase 2 Basket Clinical Trial to Evaluate ICP-723 in Patients with Advanced Solid Tumors or Primary Central Nervous System Tumors

Participants needed: 70
Trial details
Phase: Phase 1, Phase 2Age: 2+Biological sex: AllType: InterventionalSponsor: Beijing InnoCare Pharma Tech Co., Ltd.Updated: Sep 11, 2025Locations: 1
Eligibility criteria

Eastern Cooperative Oncology Group (ECOG) performance status of 0-1; [+3]

Patients with unstable primary central nervous system (CNS) tumors or CNS metast... [+4]

Read more